Randall K. Johnson

Nessuna posizione attualmente

77 anni

Health Technology

Precedenti posizioni note di Randall K. Johnson

Società	Posizione	Inizio	Fine
Callisto Pharmaceuticals, Inc. Callisto Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Callisto Pharmaceuticals, Inc. is a development stage biopharmaceutical company. The company operates through two subsidiary companies: Pharmaceuticals, Inc and Callisto Research Labs, LLC. It focuses primarily on the development of drugs to treat gastrointestinal disorder and diseases and rheumatoid arthritis and develops novel therapeutics to treat cancer. The company was founded by Judson A. Cooper and Joshua D. Schein in 1996 and is headquartered in New York, NY.	Direttore/Membro del Consiglio	10/02/2005	22/01/2013
	Independent Dir/Board Member	10/02/2005	22/01/2013
GSK PLC	Corporate Officer/Principal	01/02/2002	01/02/2002
Smithkline Beecham Pharmaceuticals (Canada)	Corporate Officer/Principal	-	-

Distribuzione geografica

Posizioni

Corporate Officer/Principal	2
Director/Board Member	1
Independent Dir/Board Member	1

Settori

Health Technology

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Società quotate in Borsa	1
GSK PLC	Health Technology

Aziende private	2
Callisto Pharmaceuticals, Inc. Callisto Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Callisto Pharmaceuticals, Inc. is a development stage biopharmaceutical company. The company operates through two subsidiary companies: Pharmaceuticals, Inc and Callisto Research Labs, LLC. It focuses primarily on the development of drugs to treat gastrointestinal disorder and diseases and rheumatoid arthritis and develops novel therapeutics to treat cancer. The company was founded by Judson A. Cooper and Joshua D. Schein in 1996 and is headquartered in New York, NY.	Health Technology
Smithkline Beecham Pharmaceuticals (Canada)

Aziende private

Health Technology

Smithkline Beecham Pharmaceuticals (Canada)